Equities Analysts Offer Predictions for LifeStance Health Group, Inc.’s Q2 2022 Earnings (NASDAQ:LFST)


LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) – Jefferies Financial Group increased their Q2 2022 earnings per share (EPS) estimates for LifeStance Health Group in a research note issued to investors on Tuesday, May 10th. Jefferies Financial Group analyst S. Wissink now expects that the company will earn ($0.02) per share for the quarter, up from their prior estimate of ($0.03). Jefferies Financial Group also issued estimates for LifeStance Health Group’s Q3 2022 earnings at ($0.01) EPS, FY2022 earnings at ($0.22) EPS, Q1 2023 earnings at $0.01 EPS, Q3 2023 earnings at $0.02 EPS, FY2023 earnings at $0.06 EPS and FY2024 earnings at $0.17 EPS.

Other research analysts have also recently issued research reports about the company. The Goldman Sachs Group lowered their price objective on LifeStance Health Group from $15.00 to $10.00 and set a “neutral” rating on the stock in a research report on Monday, March 21st. Zacks Investment Research upgraded LifeStance Health Group from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, UBS Group lowered shares of LifeStance Health Group from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $19.00 to $10.00 in a research note on Thursday, March 17th. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $16.00.

Shares of LFST stock opened at $5.83 on Thursday. The company has a current ratio of 2.28, a quick ratio of 2.28 and a debt-to-equity ratio of 0.10. The firm’s fifty day moving average price is $9.09 and its two-hundred day moving average price is $9.18. LifeStance Health Group has a 1 year low of $5.43 and a 1 year high of $29.81.

LifeStance Health Group (NASDAQ:LFST – Get Rating) last posted its earnings results on Monday, May 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.03). LifeStance Health Group had a negative return on equity of 20.93% and a negative net margin of 46.02%. The company had revenue of $203.10 million for the quarter, compared to analyst estimates of $191.47 million. The business’s quarterly revenue was up 41.9% on a year-over-year basis.

In related news, insider Kevin Michael Mullins sold 46,283 shares of LifeStance Health Group stock in a transaction dated Wednesday, April 20th. The shares were sold at an average price of $10.68, for a total transaction of $494,302.44. Following the completion of the transaction, the insider now directly owns 5,669,472 shares of the company’s stock, valued at approximately $60,549,960.96. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jesse Michael Bruff sold 18,401 shares of the business’s stock in a transaction that occurred on Monday, March 14th. The shares were sold at an average price of $7.92, for a total value of $145,735.92. The disclosure for this sale can be found here.

Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. raised its stake in LifeStance Health Group by 130.4% in the 3rd quarter. BlackRock Inc. now owns 4,607,687 shares of the company’s stock worth $66,811,000 after acquiring an additional 2,607,735 shares during the last quarter. Janus Henderson Group PLC grew its stake in LifeStance Health Group by 42.5% in the 3rd quarter. Janus Henderson Group PLC now owns 3,734,508 shares of the company’s stock valued at $54,150,000 after acquiring an additional 1,114,037 shares during the period. Principal Financial Group Inc. raised its holdings in shares of LifeStance Health Group by 7.3% during the first quarter. Principal Financial Group Inc. now owns 2,498,679 shares of the company’s stock valued at $25,261,000 after acquiring an additional 170,079 shares during the last quarter. Rock Springs Capital Management LP boosted its holdings in shares of LifeStance Health Group by 12.5% during the 3rd quarter. Rock Springs Capital Management LP now owns 1,687,500 shares of the company’s stock worth $24,469,000 after purchasing an additional 187,500 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of LifeStance Health Group during the 4th quarter valued at approximately $12,583,000. 80.71% of the stock is owned by institutional investors and hedge funds.

About LifeStance Health Group (Get Rating)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Further Reading

Earnings History and Estimates for LifeStance Health Group (NASDAQ:LFST)



Receive News & Ratings for LifeStance Health Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for LifeStance Health Group and related companies with MarketBeat.com’s FREE daily email newsletter.

#Equities #Analysts #Offer #Predictions #LifeStance #Health #Group #Incs #Earnings #NASDAQLFST

Leave a Reply

Your email address will not be published.